Image

CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors

CEA-Targeted CAR-T Therapy for Advanced Solid Tumors

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates CEA-targeted CAR-T cell therapy in patients with CEA-positive advanced solid tumors. The purpose of this study is to explore the potential effects of this investigational treatment on these tumors.

The study evaluates the safety and effectiveness of CEA-targeted CAR-T cells in a clinical setting. Researchers are interested in understanding how this treatment works and its impact on patients with these specific tumor types.

  • Who can participate: Adults aged 18 and older with advanced, metastatic, or recurrent malignant tumors, including colorectal, esophageal, gastric, pancreatic, lung cancer, and cholangiocarcinoma, may participate. Participants must have CEA-positive tumors and have failed at least second-line standard treatment.
  • Study details: Participants will receive an investigational CAR-T cell therapy targeting CEA-positive tumors.
Print
Study details
    Lung Cancer
    Gastric Cancer
    Colon Cancer
    Rectal Cancer
    Esophageal Cancer
    Pancreas Cancer

NCT07179692

Chongqing Precision Biotech Co., Ltd

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.